BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1909576)

  • 1. Structure-function relationships in human epidermal growth factor studied by site-directed mutagenesis and 1H NMR.
    Hommel U; Dudgeon TJ; Fallon A; Edwards RM; Campbell ID
    Biochemistry; 1991 Sep; 30(36):8891-8. PubMed ID: 1909576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding.
    Campion SR; Matsunami RK; Engler DA; Niyogi SK
    Biochemistry; 1990 Oct; 29(42):9988-93. PubMed ID: 2271634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional importance of Leu15 of human epidermal growth factor in receptor binding and activation.
    Nandagopal K; Tadaki DK; Lamerdin JA; Serpersu EH; Niyogi SK
    Protein Eng; 1996 Sep; 9(9):781-8. PubMed ID: 8888144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding.
    Tadaki DK; Niyogi SK
    J Biol Chem; 1993 May; 268(14):10114-9. PubMed ID: 8486681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy.
    Engler DA; Montelione GT; Niyogi SK
    FEBS Lett; 1990 Oct; 271(1-2):47-50. PubMed ID: 2172006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational characterization of a single-site mutant of murine epidermal growth factor (EGF) by 1H NMR provides evidence that leucine-47 is involved in the interactions with the EGF receptor.
    Moy FJ; Scheraga HA; Liu JF; Wu R; Montelione GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9836-40. PubMed ID: 2690076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of asparagine-32 in forming the receptor-binding epitope of human epidermal growth factor.
    Campion SR; Biamonti C; Montelione GT; Niyogi SK
    Protein Eng; 1993 Aug; 6(6):651-9. PubMed ID: 8234236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of an antiparallel beta-sheet structure of human epidermal growth factor by its receptor. Site-directed mutagenesis studies of Ala-30 and Asn-32.
    Koide H; Muto Y; Kasai H; Hoshi K; Takusari H; Kohri K; Takahashi S; Sasaki T; Tsukumo K; Miyake T
    FEBS Lett; 1992 May; 302(1):39-42. PubMed ID: 1587350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function analysis of epidermal growth factor: site directed mutagenesis and nuclear magnetic resonance.
    Dudgeon TJ; Cooke RM; Baron M; Campbell ID; Edwards RM; Fallon A
    FEBS Lett; 1990 Feb; 261(2):392-6. PubMed ID: 2178977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function studies of mEGF: probing the type I beta-turn between residues 25 and 26.
    Lester CC; Wang B; Wu R; Scheraga HA
    J Protein Chem; 1995 Nov; 14(8):753-62. PubMed ID: 8747437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor.
    van de Poll ML; Lenferink AE; van Vugt MJ; Jacobs JJ; Janssen JW; Joldersma M; van Zoelen EJ
    J Biol Chem; 1995 Sep; 270(38):22337-43. PubMed ID: 7673217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function analysis of a conserved aromatic cluster in the N-terminal domain of human epidermal growth factor.
    Murray MB; Tadaki DK; Campion SR; Lamerdin JA; Serpersu EH; Bradrick TD; Niyogi SK
    Protein Eng; 1998 Nov; 11(11):1041-50. PubMed ID: 9876925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-binding affinities of human epidermal growth factor variants having unnatural amino acid residues in position 23.
    Koide H; Yokoyama S; Katayama Y; Muto Y; Kigawa T; Kohno T; Takusari H; Oishi M; Takahashi S; Tsukumo K
    Biochemistry; 1994 Jun; 33(23):7470-6. PubMed ID: 8003512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A site-directed mutagenesis study on the role of isoleucine-23 of human epidermal growth factor in the receptor binding.
    Koide H; Muto Y; Kasai H; Kohri K; Hoshi K; Takahashi S; Tsukumo K; Sasaki T; Oka T; Miyake T
    Biochim Biophys Acta; 1992 Apr; 1120(3):257-61. PubMed ID: 1576151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor recognition by histidine 16 of human epidermal growth factor via hydrogen-bond donor/acceptor interactions.
    Nandagopal K; Terzaghi-Howe M; Niyogi SK
    J Cell Biochem; 1999 Jan; 72(1):16-24. PubMed ID: 10025663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality.
    Mullenbach GT; Chiu CY; Gyenes A; Blaney J; Rosenberg S; Marlowe CK; Brown S; Stratton-Thomas J; Montelione GT; George-Nascimento C; Stauber G
    Protein Eng; 1998 Jun; 11(6):473-80. PubMed ID: 9725626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the role of Glu-842, Glu-844 and His-846 in the function of the cytoplasmic domain of the epidermal growth factor receptor.
    Timms JF; Noble ME; Gregoriou M
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):219-29. PubMed ID: 7755568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
    Stortelers C; Souriau C; van Liempt E; van de Poll ML; van Zoelen EJ
    Biochemistry; 2002 Jul; 41(27):8732-41. PubMed ID: 12093292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
    Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
    Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail.
    Bishayee A; Beguinot L; Bishayee S
    Mol Biol Cell; 1999 Mar; 10(3):525-36. PubMed ID: 10069801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.